VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 712 filers reported holding VANECK VECTORS ETF TR in Q4 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $401,713 | -10.5% | 14,928 | +0.2% | 0.04% | -7.3% |
| Q2 2023 | $448,760 | -11.4% | 14,904 | -4.8% | 0.04% | -12.8% |
| Q1 2023 | $506,310 | -94.1% | 15,651 | -94.7% | 0.05% | -93.5% |
| Q4 2022 | $8,531,109 | +2139.1% | 297,666 | +1784.9% | 0.72% | +1794.7% |
| Q3 2022 | $381,000 | +0.8% | 15,792 | +14.5% | 0.04% | +15.2% |
| Q2 2022 | $378,000 | -27.9% | 13,795 | +1.0% | 0.03% | -17.5% |
| Q1 2022 | $524,000 | +64.3% | 13,655 | +37.2% | 0.04% | +73.9% |
| Q4 2021 | $319,000 | -10.4% | 9,951 | -17.7% | 0.02% | -17.9% |
| Q3 2021 | $356,000 | -13.4% | 12,093 | 0.0% | 0.03% | -9.7% |
| Q2 2021 | $411,000 | +1.2% | 12,093 | -3.1% | 0.03% | -3.1% |
| Q1 2021 | $406,000 | -94.7% | 12,486 | -94.1% | 0.03% | -95.0% |
| Q4 2020 | $7,626,000 | – | 211,711 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |